Enteric-coated mycophenolate sodium (EC-MPS) is comparable to mycophenolate mofetil in de novo heart transplant patients. Twelve months efficacy and safety results.

被引:0
|
作者
Kobashigawa, JA [1 ]
Gerosa, G [1 ]
Caforio, A [1 ]
Renlund, DG [1 ]
Ross, H [1 ]
Yonan, N [1 ]
Hummel, M [1 ]
Segovia, J [1 ]
Almenar, L [1 ]
Brambilla, R [1 ]
机构
[1] Univ Calif Los Angeles, Los Angeles, CA 90024 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
347
引用
收藏
页码:244 / 244
页数:1
相关论文
共 50 条
  • [1] Twelve months results of enteric-coated mycophenolate sodium (EC-MPS) in de novo heart transplant patients showed excellent efficacy and safety
    Kobashigawa, J. A.
    Renlund, D. G.
    Gerosa, G.
    Caforio, A.
    Ross, H.
    Lehmkuhl, H. B.
    Eisen, H.
    Segovia, J.
    Brambilla, R.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (02): : S166 - S166
  • [2] Enteric-coated mycophenolate sodium (EC-MPS) vs mycophenolate mofetil (MMF) in de novo heart transplant patients: 6-month efficacy and safety results.
    Kobashigawa, JA
    Davis, SF
    Renlund, DG
    Eisen, H
    Miller, L
    Lehmkuhl, H
    Gambino, A
    Brambilla, R
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 281 - 281
  • [3] Enteric-coated mycophenolate sodium (EC-MPS) in de novo heart transplant patients: Pharmacokinetic (PK) results.
    Sechaud, R
    Yeh, CM
    Balez, S
    Koelle, E
    Hummel, M
    Gerosa, G
    Yonan, N
    Ross, H
    Miller, LW
    Brambilla, R
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 250 - 250
  • [4] Conversion of Mycophenolate Mofetil (MMF) to Enteric-Coated Mycophenolate Sodium (EC-MPS) Ameliorates GI Symptoms in Liver Transplant Patients.
    de Vera, Michael E.
    Hope, Laurie
    Yelochan, Barbara
    Durant, Stephanie
    Lopez-Solis, Roberto
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 531 - 531
  • [5] USE OF ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN LIVER TRANSPLANT PATIENTS
    de Vera, Michael E.
    Lopez, Roberto
    Yelochan, Barbara
    Hope, Laurie
    Marcos, Amadeo
    Fontes, Paulo
    [J]. LIVER TRANSPLANTATION, 2008, 14 (07) : S112 - S112
  • [6] Enteric-coated mycophenolate sodium (EC-MPS) and mycophenolate mofetil (MMF), it is better to have the choice
    Budde, K
    Salvadori, M
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (05) : 1165 - 1166
  • [7] Impact of dose reductions on efficacy outcome in heart transplant patients receiving enteric-coated mycophenolate sodium (EC-MPS) or mycophenolate mofetil (MMF) at 12 months post-transplant
    Segovia, Javier
    Gerosa, Gino
    Almenar, Luis
    Livi, Ugolino
    Vigano, Mario
    Arizon, Jose Maria
    Yonan, Nizar
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 6 - 6
  • [8] Enteric-Coated Mycophenolate Sodium (EC-MPS) Has Less GI Side Effects Compared to Mycophenolate Mofetil (MMF) in Liver Transplant Patients.
    de Vera, Michael E.
    Hope, Laurie
    Kikla, Stephenie
    Fedorek, Sheila
    Durant, Stephanie
    Lopez, Roberto
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 533 - 533
  • [9] Pilot Study To Evaluate the Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Combination with Sirolimus in De Novo Renal Transplant Recipients
    Peddi, V. R.
    Wilson, J.
    Mena, N.
    Lu, L.
    Miguel, M.
    Ueda, K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 412 - 412
  • [10] Enteric-coated mycophenolate sodium (EC-MPS) improves GI symptoms and immunosuppression in patients treated with mycophenolate mofetil (MMF)
    Sabbatini, Massimo
    Mirenghi, Francesco
    Caputo, Carmela
    Capone, Domenico
    Gentile, Antonio
    Polichetti, Giuliano
    Basile, Vincenzo
    Gallo, Riccardo
    Apicella, Luca
    Federico, Stefano
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 395 - 395